VVOS — Vivos Therapeutics Share News
0.000.00%
Last trade - 00:00- $4.80m
- $11.13m
- $17.44m
Vivos Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: Vivos Therapeutics Q1 Net Income USD -3.763 Million
Brief: Vivos Therapeutics Offers Up To 1.7 Mln Shares For Sale
Vivos Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Vivos Therapeutics Inc expected to post a loss of $1.90 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-ResMed, Guidewire Software, Snowflake
U.S. STOCKS ON THE MOVE-Estee Lauder, Union Pacific, Fluence Energy
U.S. STOCKS ON THE MOVE-Dollar Tree, Phillips 66, GameStop
Vivos Therapeutics more than doubles as FDA clears sleep apnea device
US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea (updated)
US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea
Brief: Vivos Therapeutics Announces Pricing Of $4 Mln Private Placement Priced At-The-Market Under Nasdaq Rules
Brief: Vivos Therapeutics Announces Reverse Stock Split
Brief: Vivos Therapeutics Signed U.S. Nationwide Distribution Agreement With Lincare
Brief: Vivos Therapeutics To Begin Clinical Trial At Stanford Medicine
Brief: Vivos Therapeutics Announces Strategic Collaboration In MENA Region For Global Expansion
Brief: Vivos Therapeutics Executes Strategic Agreements With Ormco And On Demand Orthodontist To Provide Spark™ Clear Aligners To Its National Network Of Providers
Brief: Vivos Therapeutics Says Received Notice From Nasdaq That Co Failed To Meet Minimum Bid Requirement
Vivos Therapeutics Inc reports results for the quarter ended in June - Earnings Summary